Annual report pursuant to Section 13 and 15(d)

ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)

v3.24.1
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Dec. 27, 2023
USD ($)
Aug. 31, 2023
USD ($)
Jan. 26, 2023
USD ($)
shares
Aug. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
item
$ / shares
shares
Dec. 31, 2022
USD ($)
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Number of branded drugs in product portfolio | item         7  
Number of authorized generic prescription drugs | item         2  
Cash and cash equivalents         $ 27,439 $ 32,003
Proceeds from term-loan         15,000 $ 19,763
Stock issued value         $ 4,494  
Common stock par value | $ / shares         $ 0.0001  
Non-refundable upfront payment from Maruho            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Proceeds from non-refundable payment   $ 19,000   $ 19,000    
Common Stock            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Stock issued value     $ 150,000      
Stock issued (in shares) | shares     4,900,000   748,703  
Number of Shares Available for Issuance | shares         4,151,297  
Proceeds from issuance of common stock         $ 4,500  
Term loan | East West Bank            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Maximum borrowing capacity $ 20,000          
Proceeds from term-loan 15,000          
Outstanding principal balance voluntarily paid off         $ 20,000  
Remaining borrowing capacity. $ 5,000          
Principal amount of funded term loans 7.50%          
Term loan | East West Bank | SOFR            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Spread on variable rate 7.75%          
Floor rate 5.00%